Company Profile:
Nature of Business: DUOPHARMA M. SDN BHD is primarily a manufacturer with extensive manufacturing facilities. It also actively engages in the marketing and distribution (trading) of pharmaceutical products. Therefore, it operates as both a manufacturer and a trader.
Industry: Pharmaceutical
Overview: DUOPHARMA M. SDN BHD is a prominent subsidiary of Duopharma Biotech Berhad, a leading pharmaceutical company in Malaysia. The company is deeply involved in the research, development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products. It operates modern, Good Manufacturing Practice (GMP) compliant manufacturing plants to produce high-quality ethical (prescription) drugs, over-the-counter (OTC) medicines, and health supplements. Its operations span the entire supply chain, from raw material processing and production to packaging, marketing, and distribution to various healthcare providers and consumers.
Enterprise Products
DUOPHARMA M. SDN BHD produces or sells a wide range of pharmaceutical and consumer healthcare products. These include:
1. Generic Prescription Medicines
Examples include various antibiotics, cardiovascular drugs, diabetes medications, pain relievers, and treatments for central nervous system disorders, often marketed under the Axcel and Duopharma brands.
2. Over-the-Counter (OTC) Medicines
Such as analgesics (pain relievers), cough and cold remedies, digestive health products, and medicated creams.
3. Consumer Healthcare Products
Vitamins and Supplements: For instance, Flavettes (e.g., Vitamin C effervescent tablets), Proviton (multivitamins), and Nat C.
Personal Care: Including products like Eye Mo (eye drops).
Skincare: Medicated skincare solutions for various conditions.
4. Specialty Pharmaceutical Products
These target specific therapeutic areas such as Oncology, Nephrology, Cardiovascular diseases, Diabetes, Pain Management, Anti-infectives, Central Nervous System disorders, Gastroenterology, Respiratory conditions, Dermatology, and Urology.
5. Biologics and Biosimilars
Including advanced biological medicines.